Bone densitometry firm Hologic of Waltham, MA, announced a two-for-onestock split effective March 25. Hologic's share price has risensteadily since last year, when Merck received marketing approvalfor its Fosamax osteoporosis drug, and the split will
Bone densitometry firm Hologic of Waltham, MA, announced a two-for-one
stock split effective March 25. Hologic's share price has risen
steadily since last year, when Merck received marketing approval
for its Fosamax osteoporosis drug, and the split will make the
company's stock more affordable. Hologic's stock was trading at
around $50 a share the week before the split. It had been trading
at around $14 a share last March (SCAN 12/27/95).
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.